Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Amgen Inc. and every other company we cover.
Try it first on NVDA, AAPL, META or NKE, where it is open to everyone.
AMGN · Nasdaq · ·
Next earnings: November 3, 2026
$423.54+1.3%Sep 29 close
Amgen discovers, makes and sells prescription medicines for serious diseases, along with biosimilar medicines.